These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7669640

  • 1. Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts.
    Korting HC, Hülsebus E, Kerscher M, Greber R, Schäfer-Korting M.
    Br J Dermatol; 1995 Jul; 133(1):54-9. PubMed ID: 7669640
    [Abstract] [Full Text] [Related]

  • 2. Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro.
    Lange K, Gysler A, Bader M, Kleuser B, Korting HC, Schäfer-Korting M.
    Pharm Res; 1997 Dec; 14(12):1744-9. PubMed ID: 9453063
    [Abstract] [Full Text] [Related]

  • 3. Cutaneous inflammation and proliferation in vitro: differential effects and mode of action of topical glucocorticoids.
    Lange K, Kleuser B, Gysler A, Bader M, Maia C, Scheidereit C, Korting HC, Schäfer-Korting M.
    Skin Pharmacol Appl Skin Physiol; 2000 Dec; 13(2):93-103. PubMed ID: 10754457
    [Abstract] [Full Text] [Related]

  • 4. Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.
    Schäfer-Korting M, Korting HC, Kerscher MJ, Lenhard S.
    Clin Pharmacol Ther; 1993 Oct; 54(4):448-56. PubMed ID: 8222488
    [Abstract] [Full Text] [Related]

  • 5. Effects of mometasone furoate on human keratinocytes and fibroblasts in vitro.
    Wach F, Bosserhoff A, Kurzidym U, Nowok K, Landthaler M, Hein R.
    Skin Pharmacol Appl Skin Physiol; 1998 Oct; 11(1):43-51. PubMed ID: 9603668
    [Abstract] [Full Text] [Related]

  • 6. [The effect of hydrocortisone aceponate on proliferation, total protein synthesis and collagen synthesis in human skin fibroblasts in vitro].
    Görmar FE, Bernd A, Holzmann H.
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):192-6. PubMed ID: 2334460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Topical glucocorticoids with improved risk-benefit ratio. Rationale of a new concept.
    Schäfer-Korting M, Schmid MH, Korting HC.
    Drug Saf; 1996 Jun; 14(6):375-85. PubMed ID: 8828015
    [Abstract] [Full Text] [Related]

  • 11. Effects of glucocorticosteroids on primary human skin fibroblasts. II. Effects on total protein and collagen biosynthesis by confluent cell cultures.
    Ponec M, Hasper I, Vianden GD, Bachra BN.
    Arch Dermatol Res (1975); 1977 Aug 22; 259(2):125-34. PubMed ID: 907362
    [Abstract] [Full Text] [Related]

  • 12. Topical mometasone. A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.
    Prakash A, Benfield P.
    Drugs; 1998 Jan 22; 55(1):145-63. PubMed ID: 9463794
    [Abstract] [Full Text] [Related]

  • 13. Effects of glucocorticosteroids on primary human skin fibroblasts. I. Inhibition of the proliferation of cultured primary human skin and mouse L929 fibroblasts.
    Ponec M, de Haas C, Bachra BN, Polano MK.
    Arch Dermatol Res (1975); 1977 Aug 22; 259(2):117-23. PubMed ID: 907361
    [Abstract] [Full Text] [Related]

  • 14. Differential effect of medium potent nonhalogenated double-ester-type and conventional glucocorticoids on proliferation and chemotaxis of fibroblasts in vitro.
    Hein R, Korting HC, Mehring T.
    Skin Pharmacol; 1994 Aug 22; 7(5):300-6. PubMed ID: 8054213
    [Abstract] [Full Text] [Related]

  • 15. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
    Priestley GC.
    Br J Dermatol; 1978 Sep 22; 99(3):253-61. PubMed ID: 81679
    [Abstract] [Full Text] [Related]

  • 16. Different skin thinning potential of equipotent medium-strength glucocorticoids.
    Korting HC, Unholzer A, Schäfer-Korting M, Tausch I, Gassmueller J, Nietsch KH.
    Skin Pharmacol Appl Skin Physiol; 2002 Sep 22; 15(2):85-91. PubMed ID: 11867964
    [Abstract] [Full Text] [Related]

  • 17. Topical hydrocortisone 17-butyrate 21-propionate in the treatment of inflammatory skin diseases: pharmacological data, clinical efficacy, safety and calculation of the therapeutic index.
    Fölster-Holst R, Abeck D, Torrelo A.
    Pharmazie; 2016 Mar 22; 71(3):115-21. PubMed ID: 27183704
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of beneficial and adverse effects of glucocorticoids on a newly developed full-thickness skin model.
    Zöller NN, Kippenberger S, Thaçi D, Mewes K, Spiegel M, Sättler A, Schultz M, Bereiter-Hahn J, Kaufmann R, Bernd A.
    Toxicol In Vitro; 2008 Apr 22; 22(3):747-59. PubMed ID: 18249522
    [Abstract] [Full Text] [Related]

  • 19. Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.
    Gysler A, Lange K, Korting HC, Schäfer-Korting M.
    Pharm Res; 1997 Jun 22; 14(6):793-7. PubMed ID: 9210199
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.